Ignite Creation Date:
2024-05-06 @ 1:19 PM
Last Modification Date:
2024-10-26 @ 1:12 PM
Study NCT ID:
NCT03999645
Status:
COMPLETED
Last Update Posted:
2019-06-27
First Post:
2019-06-23
Brief Title:
Is it Safe to do Laparoscopic Cholecystectomy for Acute Cholecystitis up to Seven Days
Sponsor:
Damanhour Teaching Hospital
Organization:
Damanhour Teaching Hospital
Study Overview
Official Title:
Is it Safe to do Laparoscopic Cholecystectomy for Acute Cholecystitis up to Seven Days A Randomized Clinical Trial
Status:
COMPLETED
Status Verified Date:
2019-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RCT
Brief Summary:
Objectives To compare the safety of early 72h versus late 72h-7days laparoscopic cholecystectomy LC from symptom onset for acute cholecystitis AC
Background As LC within 72h of symptom onset was considered the optimum time sometimes there was a delay in diagnosis and management So we raised the question of safety and feasibility of performing LC to patients with AC who failed to have LC within 72h of acute attack
Patients and Methods This was a prospective randomized double-blind clinical trial carried out on 120 patients presented with AC between September 2017 and April 2019 Patients were randomly allocated into two equal groups assigned to LC group E within 72h of symptom onset and group L after 72h up to seven days from symptom onset
Background As LC within 72h of symptom onset was considered the optimum time sometimes there was a delay in diagnosis and management So we raised the question of safety and feasibility of performing LC to patients with AC who failed to have LC within 72h of acute attack
Patients and Methods This was a prospective randomized double-blind clinical trial carried out on 120 patients presented with AC between September 2017 and April 2019 Patients were randomly allocated into two equal groups assigned to LC group E within 72h of symptom onset and group L after 72h up to seven days from symptom onset
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None